|
|
Volumn 35, Issue 4, 2004, Pages
|
|
Effectively bridging the preclinical/clinical gap: the results of the ASTIN trial.
a
a
NONE
|
|
Author keywords
[No Author keywords available]
|
|
Indexed keywords
GLYCOPROTEIN;
NEUROPROTECTIVE AGENT;
UK279276;
ACUTE DISEASE;
ANIMAL;
CEREBROVASCULAR ACCIDENT;
CEREBROVASCULAR DISEASE;
CLINICAL TRIAL;
DRUG EFFECT;
DRUG SCREENING;
HUMAN;
MOUSE;
NEUTROPHIL;
NOTE;
RAT;
ACUTE DISEASE;
ANIMALS;
CEREBROVASCULAR ACCIDENT;
CEREBROVASCULAR DISORDERS;
CLINICAL TRIALS;
DRUG EVALUATION, PRECLINICAL;
GLYCOPROTEINS;
HUMANS;
MICE;
NEUROPROTECTIVE AGENTS;
NEUTROPHILS;
RATS;
MLCS;
MLOWN;
|
|
EID: 12144289105
PISSN: None
EISSN: 15244628
Source Type: Journal
DOI: 10.1161/01.str.0000121164.29117.44 Document Type: Note |
|
Times cited : (11)
|
|
References (0)
|
